Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL60768 | 1.00 | FFAR3 (0.44) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL4800886 | 0.96 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL28088226 | 0.96 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL28103153 | 0.96 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL4800891 | 0.96 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL4312446 | 0.96 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL28065786 | 0.96 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL10783748 | 0.93 | ALDH1A1 (0.40) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL28333973 | 0.93 | FFAR3 (0.39) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Isobutane SCHEMBL27500548 | 0.90 | CHRM2 (0.43) | FFAR3CHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 686 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091106-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING STABILIZED ENVELOPED VIRUSES BY SPRAY-DRYING AND LYOPHILIZATION | UNIV COLORADO REGENTS (US) | 2026-04-02 | — | — | US | claimed |
| US-20260014251-A1 | COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE | VITRIVAX INC (US) | 2026-01-15 | — | — | US | claimed |
| US-20260014093-A1 | ATOMIC LAYER DEPOSITION (ALD) PROCESSES APPLIED TO PHAGE AND PHAGE-LIKE PARTICLE PLATFORM YIELD THERMOSTABLE THERAPEUTIC AGENTS | UNIV COLORADO REGENTS (US) | 2026-01-15 | — | — | US | claimed |
| EP-4651855-A1 | COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE | Vitrivax, Inc. (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250352633-A1 | COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE BROAD-SPECTRUM HUMAN PAPILLOMAVIRUS FORMULATIONS | UNIV COLORADO REGENTS (US) | 2025-11-20 | — | — | US | claimed |
| US-12447127-B2 | Thermostable vaccine compositions and methods of preparing the same | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2025-10-21 | — | — | US | claimed |
| US-12303602-B2 | Compositions, methods and uses for thermally stable multi-targeted antigens | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2025-05-20 | — | — | US | claimed |
| WO-2025029323-A1 | COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE | VITRIVAX, INC. (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2024211446-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING STABILIZED ENVELOPED VIRUSES BY SPRAY-DRYING AND LYOPHILIZATION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2024-10-10 | — | — | WO | claimed |
| US-12097291-B2 | Thermostable vaccine compositions and methods of preparing same | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2024-09-24 | — | — | US | claimed |
| WO-2012158978-A1 | THERMOSTABLE VACCINE COMPOSITIONS AND METHODS OF PREPARING SAME | SOLIGENIX, INC. (US) | 2012-11-22 | — | — | WO | claimed |
| EP-2066653-B1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS | ROTTAPHARM SPA (IT) | 2012-09-12 | — | — | EP | claimed |
| JP-2011524383-A | — | — | 2011-09-01 | — | — | JP | claimed |
| US-20110118289-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS | ROTTAPHARM S.P.A. (IT) | 2011-05-19 | — | — | US | claimed |
| EP-2315588-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS | Rottapharm S.p.A. (IT) | 2011-05-04 | — | — | EP | claimed |
| WO-2009152868-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS | ROTTAPHARM S.P.A. (IT) | 2009-12-23 | — | — | WO | claimed |
| US-20090264451-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS | ROTTAPHARM S.P.A. (IT) | 2009-10-22 | — | — | US | claimed |
| EP-2066653-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS | Rottapharm S.p.A. (IT) | 2009-06-10 | — | — | EP | claimed |
| WO-2008014822-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS | ROTTAPHARM S.P.A. (IT) | 2008-02-07 | — | — | WO | claimed |
| US-4844744-A | Liquid, phosphate-free single phase degreasing compositions | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1989-07-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014251-A1 | COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE | TREH, PNP, RNGTT | FFAR3 3188/4885CHRM2 4510/4885CHRM4 3772/4885 |
| US-20090264451-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS | IL1A, IL6, IL1B | FFAR3 939/4885CHRM2 2309/4885CHRM4 3266/4885 |
| US-20260014093-A1 | ATOMIC LAYER DEPOSITION (ALD) PROCESSES APPLIED TO PHAGE AND PHAGE-LIKE PARTICLE PLATFORM YIELD THERMOSTABLE THERAPEUTIC AGENTS | ALDOA, AGL, SORD | FFAR3 4163/4885CHRM2 1232/4885CHRM4 1554/4885 |
| US-20110118289-A1 | 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS | OPRM1, OPRD1, HTR3C | FFAR3 228/4885CHRM2 44/4885CHRM4 70/4885 |
| US-20260091106-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING STABILIZED ENVELOPED VIRUSES BY SPRAY-DRYING AND LYOPHILIZATION | CFD, TREH, TMED2 | FFAR3 1866/4885CHRM2 4580/4885CHRM4 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.